Objective: To explore the risk factors of ventilator-associated pneumonia (VAP) in premature infants with respiratory distress syndrome (RDS) undergoing assisted ventilation. Methods: A total of 100 premature infants with RDS who received assisted ventilation in Quanzhou First Hospital from May 2020 to May 2022 were selected as observation targets. The incidence of VAP during assisted ventilation was counted. According to the occurrence of VAP, they were divided into VAP group and non-VAP group. The risk factors of VAP during assisted ventilation in premature infants with RDS were analyzed by univariate and multivariate logistic regression analysis. Results: There were 34 premature infants of VAP and 66 premature infants of non-VAP in 100 premature infants with RDS during assisted ventilation, and the incidence of VAP was 34% (34/100). Univariate analysis showed that the time of invasive mechanical ventilation treatment, the time of non-invasive ventilation treatment after extubation, the rate of neonatal asphyxia, the rate of neonatal rescue, and the number of repeated intubations in the VAP group were higher than those in the non-VAP group, the difference was statistically significant (P<0.05). Multivariate Logistic regression analysis showed that the time of invasive mechanical ventilation treatment, the time of non-invasive ventilation treatment after extubation, neonatal asphyxia, neonatal rescue, and the number of repeated intubations >3 times were independent risk factors for VAP during assisted ventilation treatment in preterm infants with RDS (P<0.05). Conclusion: There is a high possibility of VAP in premature infants with RDS during assisted ventilation due to factors such as mechanical ventilation treatment time, neonatal asphyxia and repeated intubation.
WANG Liqiong
,
WANG Qifan
,
ZHANG Yadi
. Risk factors of VAP in preterm infants with RDS treated with assisted ventilation[J]. Journal of Baotou Medical College, 2024
, 40(9)
: 52
-55
.
DOI: 10.16833/j.cnki.jbmc.2024.09.010
[1] 黄静,林新祝,巴瑞华.三种无创通气模式在早产儿呼吸窘迫综合征初始治疗中的临床应用[J].中国小儿急救医学,2021,28(7):603-608.
[2] 张慧,彭万胜.NIPPV和NCPAP联合LISA技术治疗早产儿呼吸窘迫综合征效果观察[J].山东医药,2022,62(22):71-74.
[3] 马卫丽.呼吸窘迫综合征新生儿并发呼吸机相关性肺炎的影响因素[J].河南医学研究,2020,29(21):3902-3904.
[4] 刘玉娟,楚艳艳,李丽红,等.呼吸窘迫综合征极低和超低出生体重早产儿呼吸机相关性肺炎临床分析[J].潍坊医学院学报,2021,43(1):42-45.
[5] 王卫平,孙锟,常立文.儿科学[M].9版.北京:人民卫生出版社,2018:105-125.
[6] 雷一慧,林素,潘冰婷,等.机械通气新生儿气管导管的生物膜菌群分析及其与呼吸机相关性肺炎的关系[J].中华传染病杂志,2022,40(11):656-662.
[7] 赵勍,贺晓春,何婧,等.儿童重症监护病房发生呼吸机相关性肺炎的危险因素分析[J].东南国防医药,2022,24(4):377-381.
[8] 杨立娜.咖啡因预防早产儿呼吸机相关性肺炎的作用[J].临床与病理杂志,2021,41(1):52-59.
[9] 万有仓,潘秀娟.PICU患儿发生呼吸机相关性肺炎的影响因素[J].临床肺科杂志,2021,26(1):36-39,44.
[10] 谢朝云,熊芸,蒙桂鸾,等.新生儿呼吸窘迫综合征合并呼吸机相关性肺炎患儿死亡相关因素Logistic回归分析[J].湖北民族大学学报(医学版),2020,37(1):35-38.
[11] 许津莉,郭华贤,王佳慧,等.早产儿呼吸机相关性肺炎病原菌及危险因素[J].中华医院感染学杂志,2021,31(6):919-923.
[12] 杨翠媖,钟晓波.新生儿重症监护病房呼吸机相关性肺炎患儿肺部感染的耐药菌谱及相关危险因素分析[J].中国妇幼保健,2021,36(22):5279-5282.